Most SOD1 mutations are pathogenic, and their identification can lead to early access to treatment

De La Cruz, E., Esselin, F., Polge, A., Mouzat, K., & Guissart, C. (2024, December 1). Most SOD1 mutations are pathogenic, and their identification can lead to early access to treatment. Journal of Neurology, Neurosurgery and Psychiatry. BMJ Publishing Group. https://doi.org/10.1136/jnnp-2024-333939